Innovating Works

AFFILOGIC

Desconocido
NAVIPP: New AntiVirals for Infections with Pandemic Potential AFFILOGIC participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 For infectious disease management and control, vaccines are considered golden countermeasures. but are not the most adequate tool for mitiga...
2023-11-22 - 2028-12-31 | Financiado
DiViNe: Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies novel a... AFFILOGIC participó en un H2020: H2020-BIOTEC-2014-2015 In the vaccine industry, downstream processing is of extreme importance. Prophylactic vaccines aim at protecting healthy people, so any cont...
2015-02-11 - 2020-02-29 | Financiado
SADEL: Scaffolds for alternative delivery AFFILOGIC participó en un FP7: The SME-based SADEL consortium intends to develop the first generation of oral bio-therapeutics tackling disease targets in the digestive tr...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.